EPIS® Právní systém | Plné znění

XXŘ&Xxxxxx;XXX&Xxxxxx; XXXXXX (XX) 2016/1179

xx dne 19. čxxxxxxx 2016,

xxxx&xxxxxx;x xx xxx &xxxxxx;čxxx xřxxxůxxxxx&xxxxxx; xěxxxxxxxxxxxxx&xxxxxx;xx xxxxxxx xěx&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;

(Text s x&xxxxxx;xxxxxx xxx XXX)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx xx Smlouvu x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; Xxxxxxx&xxxxxx; xxxx,

s ohledem xx xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1272/2008 xx dne 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;, x&xxxx;xxěxě x&xxxx;xxx&xxxxxx;xx&xxxxxx; xxěxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxěxě xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1907/2006 (1), x&xxxx;xxxx&xxxxxx;xx na čx.&xxxx;37 xxxx.&xxxx;5 uvedeného xxř&xxxxxx;xxx&xxxxxx;,

vzhledem x&xxxx;xěxxx xůxxxůx:

(1)

Část 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 obsahuje xxx seznamy harmonizovaných xxxxxxxxxx&xxxxxx; a označení nebezpečných x&xxxxxx;xxx. X&xxxx;xxxxxxx 3.1 xx xxxxxx xxxxxx xxxxxxxxxxxx&xxxxxx;xx klasifikací a označení xxxxxxxčx&xxxxxx;xx látek na x&xxxxxx;xxxxě kritérií xxxxxxxx&xxxxxx;xx x&xxxx;č&xxxxxx;xxxxx 2 až 5 xř&xxxxxx;xxxx X&xxxx;xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008. X&xxxx;xxxxxxx 3.2 xx xxxxxx xxxxxx harmonizovaných xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx látek xx základě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx x&xxxx;xř&xxxxxx;xxxx XX xxěxxxxx Rady 67/548/EHS (2).

(2)

Xxxxxxxx x&xxxx;xxxx, že směrnice 67/548/XXX byla s účinkem xx 1.&xxxx;čxxxxx&xxxx;2015 xxx&xxxxxx;xxx, xěxx xx být xxx&xxxxxx;xxx i tabulka 3.2 x&xxxx;xř&xxxxxx;xxxx XX části 3. Xxx xx x&xxxxxx;xx xxxxxxxx xřxxxxx x&xxxx;xxx&xxxxxx;xx xxxxxňxx&xxxxxx;x&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008, nemělo xx xxxxxx&xxxxxx; xxx&xxxxxx;xx&xxxxxx; xxx&xxxxxx;x &xxxxxx;čxxxx xř&xxxxxx;xx xxž 1.&xxxx;čxxxxx&xxxx;2017.

(3)

Xxxxxxx&xxxxxx; xxxxxxřx xxx xxxxxxx&xxxxxx; x&xxxxxx;xxx (XXXX) xxxx v souladu x&xxxx;čx&xxxxxx;xxxx&xxxx;37 nařízení (ES) č.&xxxx;1272/2008 předloženy x&xxxxxx;xxxx xx xxx&xxxxxx;, xxxxxxxxxxxx&xxxxxx; xxxx xxx&xxxxxx;xx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx a označení xěxxxx&xxxxxx;xx x&xxxxxx;xxx. Xx základě xxxxxxxxxx x&xxxx;xěxxx x&xxxxxx;xxxůx, xxxx&xxxxxx; xxxxx X&xxxxxx;xxx xxx xxxxxxx&xxxxxx;x&xxxxxx; xxxxx (XXX) xůxxx&xxxxxx;x&xxxxxx; x&xxxx;x&xxxxxx;xxx Xxxxxxx&xxxxxx; xxxxxxxx pro xxxxxxx&xxxxxx; látky, jakož x&xxxx;xřxxxx&xxxxxx;xxx x&xxxxxx;čxxxxěx&xxxxxx;xx stran, xx xxxxx&xxxxxx; zavést, xxxxxxxxxxxx čx zrušit xxxxxxxxxxxx&xxxxxx; klasifikace x&xxxx;xxxxčxx&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(4)

Xxxxx xxx x&xxxx;x&xxxxxx;xxx „olovo“, XXX xxxxxxxx ve xx&xxxxxx;x xěxxxx&xxxxxx;x xxxxxxxxxx ze xxx 5.&xxxx;xxxxxxxx&xxxx;2013 klasifikovat xx jako toxickou xxx xxxxxxxxxx xxxxxxxxx 1&xxxx;X. Xx&xxxxxx;xx vzhledem x&xxxx;xxxx, žx xxxxxxxxxx xxxxxxx xxxxxxě biologické xxxxxxxxxxx olova x&xxxx;xxxxxxx&xxxxxx; xxxxě, xx xřxxx xxxxx&xxxxxx;xxxx mezi celistvou xxxxxx (xxxxxxxx částic xěx&xxxxxx;&xxxxxx; nebo xxxxx 1&xxxx;xx) x&xxxx;xx&xxxxxx;&xxxxxx;xxxxx xxxxxx (xxxxxxxx č&xxxxxx;xxxx xxx&xxxxxx;&xxxxxx; xxž 1&xxxx;xx). Je xxxxx xxxxx&xxxxxx;, aby xxx xxxxxxx specifický xxxxxxxxxčx&xxxxxx; xxxxx (SCL) &xx;&xxxx;0,03 % xxx xx&xxxxxx;&xxxxxx;xxxxx xxxxx x&xxxx;xxxxx&xxxxxx; xxxxxxxxxčx&xxxxxx; xxxxx (XXX) &xx;&xxxx;0,3 % xxx xxxxxxxxx formu.

(5)

Xxxxx jde x&xxxx;x&xxxxxx;xxx xxxxxxx&xxxxxx;x&xxxxxx; xěď, xěxx xx x&xxxxxx;x xx xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; č. 1272/2008 xxřxxxxx xxxxxxxxxxx&xxxxxx;xx&xxxxxx; xxxxxxxxxxx doporučená xx stanoviscích RAC xx dne 4.&xxxx;xxxxxxxx&xxxx;2014, xxxxxxž xxxx x&xxxx;xxxxxxxxx xxxxxxxčx&xxxxxx; vědecké důkazy xxůxxxňxx&xxxxxx;x&xxxxxx; xxxx xxxxx xxxxxxxxxxx. Navrhované xxxxxxxxxxčx&xxxxxx; xxxxxxx xxx dlouhodobou xxxxxxxčxxxx xxx xxxx&xxxxxx; xxxxxřxx&xxxxxx; xx však xxxxxxxx být xxxěxx, xxxxť xxžxxxx&xxxxxx; xxx&xxxxxx;&xxxxxx; xxxxxxxx&xxxxxx; výborem XXX xxxxxxxx k vědeckým &xxxxxx;xxxůx x&xxxx;xxxxxxxě pro xxxx&xxxxxx; xxxxxřxx&xxxxxx; xxxxxxxxxxx&xxxxxx;x ze xxxxxx xxxěxx&xxxxxx; xxx&xxxxxx;, xx xxxx xxxxxxxxxx x&xxxxxx;xxxx XXX předáno Xxxxxx.

(6)	Xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008 xx xxxxx xěxx x&xxxxxx;x xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x xxůxxxxx xxěxěxx.

(7)

Xxxxžxx&xxxxxx;x&xxxxxx; xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; xx xxxěxx x&xxxxxx;x xxžxxxx&xxxxxx;xx xxxxx, xxxxxxž dodavatelé xxxxx xxxřxxxxxx xxčxx&xxxxxx; čxxxx&xxxxxx; xxxxx&xxxxxx; na xx, xxx přizpůsobili xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx; xxx&xxxxxx;x xxxxxxxxxx&xxxxxx;x a prodali xx&xxxxxx;xxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxxx. Xxxx xxxxx&xxxxxx; xxxx rovněž xxxx&xxxxxx; k tomu, aby xx xxxxxxxxx&xxxxxx; xxxxx xřxxxůxxxxx xxx&xxxxxx;&xxxxxx;x xxxxxxxxxxx&xxxxxx;x xxxxxxxxxxx, xxxx&xxxxxx; xxxx&xxxxxx;xxx&xxxxxx; x&xxxx;xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx, xxxř. xxxxxxxxxxx xxxxxxxx&xxxxxx;x x&xxxx;čx.&xxxx;22 x&xxxxxx;xx. x) xxxx v článku 23 xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1907/2006 (3), x&xxxx;čx&xxxxxx;xxx&xxxx;50 nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;528/2012 (4) nebo v článku 44 xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1107/2009 (5), x&xxxx;xxx xx mohli xxxxxx.

(8)

X&xxxx;xxxxxxx x&xxxx;xřxxxxxx&xxxxxx;xx ustanoveními xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xxxx&xxxxxx; xxxžňxx&xxxxxx; xxxxxxxxxě xxxž&xxxxxx;x nová xxxxxxxxx&xxxxxx; xř&xxxxxx;xx, xx xxxxxxxxx&xxxxxx; xěxx mít xxžxxxx xxxž&xxxxxx;x xxx&xxxxxx; harmonizované xxxxxxxxxxx x&xxxx;xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x xxůxxxxx xxxxxxxxxě xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; xřxx xxůxxx x&xxxx;xxxxžxx&xxxxxx; xxxxxxx.

(9)	Opatření xxxxxxxx&xxxxxx; x&xxxxxx;xxx nařízením xxxx x&xxxx;xxxxxxx xx stanoviskem x&xxxxxx;xxxx xř&xxxxxx;xxx&xxxxxx;xx čx&xxxxxx;xxxx&xxxx;133 xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1907/2006,

XŘXXXXX XXXX XXŘ&Xxxxxx;XXX&Xxxxxx;:

Čx&xxxxxx;xxx&xxxx;1

Xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008 xx xěx&xxxxxx; xxxxx:

1)	Příloha XX se xěx&xxxxxx; x&xxxx;xxxxxxx x&xxxx;xř&xxxxxx;xxxxx tohoto xxř&xxxxxx;xxx&xxxxxx;.

2)	X&xxxx;xř&xxxxxx;xxxx VI se xxx&xxxxxx;xxx tabulka 3.2.

Čx&xxxxxx;xxx&xxxx;2

1.&xxxx;&xxxx;&xxxx;Xxxx xxř&xxxxxx;xxx&xxxxxx; vstupuje x&xxxx;xxxxxxxx dvacátým xxxx xx xxxx&xxxxxx;&xxxxxx;xx&xxxxxx; x&xxxx;&Xxxxxx;řxxx&xxxxxx;x xěxxx&xxxxxx;xx Xxxxxxx&xxxxxx; xxxx.

2.&xxxx;&xxxx;&xxxx;Xxxx xxř&xxxxxx;xxx&xxxxxx; xx použije xx 1. xřxxxx 2018.

Xxxxxxxxx&xxxxxx; čx.&xxxx;1 xxxx.&xxxx;2 xx xxxžxxx od 1.&xxxx;čxxxxx&xxxx;2017.

3.&xxxx;&xxxx;&xxxx;Xxxxxxxě xx odstavce 2 mohou x&xxxxxx;x x&xxxxxx;xxx a směsi xřxx xxxx 1. xřxxxx 2018 xxxxxxxxxx&xxxxxx;xx, xxxxčxx&xxxxxx;xx x&xxxx;xxxxxx v souladu x&xxxx;xxř&xxxxxx;xxx&xxxxxx;x (XX) č. 1272/2008 ve xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;.

Xxxx xxxxxxxx xx xxxxxxx v celém xxxxxxx x&xxxx;xxxxx xxxxxxxxxx ve xxxxx členských xxxxxxx.

X&xxxx;Xxxxxxx xxx 19. xxxxxxxx 2016.

Xx Xxxxxx

xxxxxxxx

Xxxx-Xxxxxx XXXXXXX

(1) Úř. věst. X&xxxx;353, 31.12.2008, s. 1.

(2) Směrnice Xxxx 67/548/EHS xx dne 27.&xxxx;xxxxxx&xxxx;1967 x&xxxx;xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxx týkajících xx xxxxxxxxxxx, balení a označování xxxxxxxxxxxx látek (Xx. xxxx. 196, 16.8.1967, x.&xxxx;1).

(3) Nařízení Xxxxxxxxxx parlamentu x&xxxx;Xxxx (ES) x.&xxxx;1907/2006 xx xxx 18.&xxxx;xxxxxxxx&xxxx;2006 x&xxxx;xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxxxx xxxxx, x&xxxx;xxxxxxx Evropské agentury xxx xxxxxxxx xxxxx, x&xxxx;xxxxx xxxxxxxx 1999/45/XX x&xxxx;x&xxxx;xxxxxxx xxxxxxxx Xxxx (XXX) x.&xxxx;793/93, xxxxxxxx Xxxxxx (XX) č. 1488/94 x&xxxx;xxxxxxxx Xxxx 76/769/XXX, Xx. věst. L 396, 30.12.2006, x.&xxxx;1.

(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (EU) č. 528/2012 xx dne 22.&xxxx;xxxxxx&xxxx;2012 x&xxxx;xxxxxxxx biocidních xxxxxxxxx xx trh x&xxxx;xxxxxx xxxxxxxxx (Xx. xxxx. X&xxxx;167, 27.6.2012, x.&xxxx;1).

(5)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1107/2009 xx dne 21.&xxxx;xxxxx&xxxx;2009 x&xxxx;xxxxxxx xxxxxxxxx xx xxxxxxx rostlin na xxx x&xxxx;x&xxxx;xxxxxxx xxxxxxx Xxxx 79/117/XXX x&xxxx;91/414/XXX (Xx. xxxx. X&xxxx;309, 24.11.2009, x.&xxxx;1).

XXXXXXX

Xxxxxxx 3.1, xxxxx 3, xxxxxxx VI, xxxxxxxx (XX) x.&xxxx;1272/2008 xx xxxx takto:

a)	položky xxxxxxxxxxxx xxxxxxxxx číslům 607-331-00-5 a 609-066-00-0 se xxxxxxx;

xxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxxx 006-035-00-8, 029-002-00-X, 602-020-00-0, 602-033-00-1, 603-055-00-4, 604-030-00-0, 604-092-00-9, 605-013-00-0, 605-022-00-X, 606-014-00-9, 606-021-00-7, 607-056-00-0, 607-059-00-7, 607-157-00-X, 607-172-00-1, 607-375-00-5, 607-623-00-2, 613-166-00-X, 613-121-00-4, 616-011-00-4, 616-037-00-6 a 616-207-00-X se xxxxxxxxx těmito xxxxxxxxxxx xxxxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx koncent. xxxxxx, xxxxxxxxxxxxx xxxxxxx	Xxxx.
Xxxxxxxx xxxxx	Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxx xxxx x&xxxx;xxxxxxxxx nebezpečnosti	Kódy xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx výstražných xxxxxxx x&xxxx;xxxxxxxxxx slov	Kódy xxxxxxxxxxxx vět o nebezpečnosti	Kódy xxxxx. standardních vět x&xxxx;xxxxxxxxxxxxx	Xxxxxxxxxx koncent. xxxxxx, xxxxxxxxxxxxx xxxxxxx	Xxxx.
„006-035-00-8	xxxxxxxxxx (XXX); 2-(xxxxxxxxxxxxx)-5,6-xxxxxxxxxxxxxxxxx-4-xx xxxxxxxxxxxxxxxx	245-430-1	23103-98-2	Xxxx. 2 Xxxxx Tox. 3 Xxxxx Xxx. 3 Skin Xxxx. 1 Aquatic Acute 1 Xxxxxxx Xxxxxxx 1	X351 X331 X301 X317 X400 X410	XXX08 XXX06 XXX09 Xxx	X351 X331 X301 X317 X410		X&xxxx;= 10 X&xxxx;= 100“
„029-002-00-X	oxid xxxxx	215-270-7	1317-39-1	Xxxxx Xxx. 4 Xxxxx Xxx. 4 Eye Dam. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X332 X302 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X332 X302 X318 X410		X&xxxx;= 100“
„602-020-00-0	1,2-xxxxxxxxxxxxx; xxxxxxxxxxxxxxxxx	201-152-2	78-87-5	Xxxx. Xxx. 2 Xxxx. 1B Acute Xxx. 4* Acute Xxx. 4*	X225 X350 X332 X302	XXX02 XXX08 XXX07 Xxx	X225 X350 X332 X302“
„602-033-00-1	xxxxxxxxxxx	203-628-5	108-90-7	Xxxx. Xxx. 3 Xxxxx Xxx. 4 Xxxx Xxxxx. 2 Xxxxxxx Xxxxxxx 2	H226 H332 H315 H411	GHS02 GHS07 GHS09 Wng	H226 H332 H315 H411“
„603-055-00-4	propylenoxid; 1,2-epoxypropan; xxxxxxxxxxxx	200-879-2	75-56-9	Xxxx. Xxx. 1 Xxxx. 1X Xxxx. 1X Xxxxx Xxx. 3 Xxxxx Xxx. 3 Xxxxx Xxx. 4 STOT SE 3 Xxx Xxxxx. 2	X224 X350 X340 X331 X311 X302 X335 X319	XXX02 XXX08 XXX06 Xxx	X224 X350 X340 X331 X311 X302 X335 X319“
„604-030-00-0	xxxxxxxx X; 4,4′-xxxxxxxxxxxxxxxxxxxx	201-245-8	80-05-7	Xxxx. 1X XXXX SE 3 Xxx Xxx. 1 Xxxx Xxxx. 1	X360X X335 X318 X317	XXX08 XXX05 GHS07 Dgr	H360F H335 H318 H317“
„604-092-00-9	dodecylfenol, xxxxxxxxxx; [1] 2-xxxxxxxxxxxx, rozvětvený; [2] 3-xxxxxxxxxxxx, xxxxxxxxxx; [3] 4-xxxxxxxxxxxx, xxxxxxxxxx; [4] xxxxxxxx tetrapropenylfenolu [5]	310-154-3 [1] [2] [3] [4] [5]	121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5]	Xxxx. 1X Xxxx Xxxx. 1X Xxx Dam. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X360X X314 X318 X400 X410	XXX08 XXX05 XXX09 Xxx	X360X X314 X410		X&xxxx;= 10 X&xxxx;= 10“
„605-013-00-0	xxxxxxxxxx (XXX); (X)-1,2-X-(2,2,2-xxxxxxxxxxxxxxxxx)-α-X-xxxxxxxxxxxxx; xxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxxxxx	240-016-7	15879-93-3	Xxxxx Tox. 4* Xxxxx Xxx. 3 XXXX XX 3 Aquatic Acute 1 Xxxxxxx Chronic 1	H332 H301 H336 H400 H410	GHS06 GHS09 Dgr	H332 H301 H336 H410		M = 10 X&xxxx;= 10	X“
„605-022-00-X	xxxxxxxx; xxxxxxxxxxxxx; 1,5-xxxxxxxxxx	203-856-5	111-30-8	Xxxxx Xxx. 2 Xxxxx Xxx. 3 XXXX XX 3 Xxxx Xxxx. 1X Xxxx. Xxxx. 1 Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 2	X330 X301 X335 X314 X334 X317 X400 X411	XXX06 XXX05 XXX08 XXX09 Xxx	X330 X301 X335 X314 X334 X317 X410	XXX071	XXXX XX 3; X335: 0,5 % ≤ C &xx;&xxxx;5 % X&xxxx;= 1“
„606-014-00-9	chlorfacinon (XXX); 2-[2-(4-xxxxxxxxxx)-2-xxxxxxxxxxx]xxxxx-1,3-xxxx	223-003-0	3691-35-8	Xxxx. 1X Xxxxx Xxx. 1 Xxxxx Xxx. 1 Acute Tox. 1 XXXX XX 1 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (krev) H400 H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H310 H300 H372 (xxxx) X410		Xxxx. 1X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥&xxxx;0,1 % XXXX XX 2; X373 (krev): 0,01 % ≤ X &xx;&xxxx;0,1 % M = 1 X&xxxx;= 1“
„606-021-00-7	X-xxxxxx-2-xxxxxxxxxx; 1-methylpyrrolidin-2-on	212-828-1	872-50-4	Repr. 1B STOT XX 3 Xxxx Irrit. 2 Xxx Irrit. 2	H360D*** H335 H315 H319	GHS08 GHS07 Dgr	H360D*** H335 H315 H319		STOT XX 3; X335: X ≥ 10 %“
„607-056-00-0	warfarin (XXX); 4-xxxxxxx-3-(1-xxxxx-3-xxxxxxxx)-2X-xxxxxxx-2-xx; [1] (X)-4-xxxxxxx-3-(1-xxxxx-3-xxxxxxxx)-2X-xxxxxxx-2-xx; [2] (X)-4-xxxxxxx-3-(1-xxxxx-3-xxxxxxxx)-2X-xxxxxxx-2-xx; [3]	201-377-6 [1] 226-907-3 [2] 226-908-9 [3]	81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3]	Xxxx. 1&xxxx;X Xxxxx Xxx. 1 Acute Tox. 1 Xxxxx Xxx. 2 STOT XX 1 Xxxxxxx Xxxxxxx 2	X360X X330 X310 X300 X372 (xxxx) X411	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X411		Xxxx. 1&xxxx;X; H360D: C ≥&xxxx;0,003 % XXXX XX 1; X372 (krev): X ≥&xxxx;0,5 % STOT XX 2; X373 (krev): 0,05 % ≤ X < 0,5 %“
„607-059-00-7	xxxxxxxxxxxx (XXX); 4-xxxxxxx-3-(1,2,3,4-xxxxxxxxxx-1-xxxxxx)-2X-xxxxxxx-2-xx	227-424-0	5836-29-3	Xxxx. 1B Acute Xxx. 2 Acute Xxx. 3 Xxxxx Xxx. 2 STOT XX 1 Xxxxxxx Xxxxxxx 1	X360X X330 X311 X300 X372 (krev) H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H311 H300 H372 (xxxx) X410		Xxxx. 1X; X360X: C ≥&xxxx;0,003 % XXXX RE 1; H372 (xxxx): X ≥&xxxx;1,0 % XXXX XX 2; X373 (xxxx) 0,1 % ≤ X &xx;&xxxx;1,0 % X&xxxx;= 10“
„607-157-00-X	xxxxxxxxx (XXX); 3-[3-(xxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	259-978-4	56073-07-5	Xxxx. 1X Xxxxx Tox. 1 Xxxxx Tox. 1 Acute Xxx. 1 XXXX RE 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H360D H330 H310 H300 H372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1X; H360D: C ≥&xxxx;0,003 % XXXX XX 1; X372 (krev): X ≥ 0,02 % XXXX XX 2; X373 (krev): 0,002 % ≤ X &xx;&xxxx;0,02 % X&xxxx;= 10 X&xxxx;= 10“
„607-172-00-1	xxxxxxxxxx (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	259-980-5	56073-10-0	Xxxx. 1 A Acute Xxx. 1 Xxxxx Xxx. 1 Acute Xxx. 1 STOT XX 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H360D H330 H310 H300 H372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1 A; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥&xxxx;0,02 % XXXX RE 2; X373 (krev): 0,002 % ≤ X &xx;&xxxx;0,02 % X&xxxx;= 10 M = 10“
„607-375-00-5	xxxxxxxxxx (XXX); xxxxxxx směs xxx-4-xxxxxxx-3-[3-(4{[4-(xxxxxxxxxxxxxx)xxxxxx]xxx}xxxxx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-2X-xxxxxxx-2-xx a trans-4-hydroxy-3-[3-(4{[4-(trifluormethyl)benzyl]oxy}fenyl)-1,2,3,4-tetrahydro-1-naftyl]-2H-chromen-2-on	421-960-0	90035-08-8	Repr. 1B Acute Xxx. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 1 XXXX XX 1 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	H360D H330 H310 H300 H372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (krev) H410		Repr. 1X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥ 0,05 % XXXX XX 2; X373 (xxxx): 0,005 % ≤ C < 0,05 % X&xxxx;= 10 X&xxxx;= 10“
„607-623-00-2	diisobutyl-ftalát	201-553-2	84-69-5	Repr. 1X	X360Xx	XXX08 Xxx	X360Xx“
„613-166-00-X	xxxxxxxxxxx (XXX); 7-xxxxx-4-(xxxx-2-xx-1-xx)-6-(3,4,5,6-xxxxxxxxxxxxxxxxxxx)-1,4-xxxxxxxxxx-3(2X)-xx	—	103361-09-7	Xxxx. 1B Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X400 X410	XXX08 XXX09 Xxx	X360X X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 1 000 “
„613-121-00-4	xxxxxxxxxxxxx (XXX); 1-(2-xxxxxxxxxxxxxxxxxxx)-3-(4,6-xxxxxxxx-1,3,5-xxxxxxx-2-xx)xxxxxxxx	265-268-5	64902-72-3	Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100“
„616-011-00-4	X,X-xxxxxxxxxxxxxxxx	204-826-4	127-19-5	Xxxx. 1X Xxxxx Xxx. 4* Acute Xxx. 4*	X360X*** X332 X312	XXX08 XXX07 Xxx	X360X*** X332 X312“
„616-037-00-6	xxxxxxxxxx (XXX); X-(xxxxxxxxxxxx)-X-(2-xxxxx-6-xxxxxxxxxxx)-2-xxxxxxxxxxxxx	251-899-3	34256-82-1	Xxxx. 2 Xxxx. 2 Xxxxx Xxx. 4 XXXX SE 3 XXXX XX 2 Xxxx Xxxxx. 2 Skin Sens. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X351 X361x X332 X335 X373 (xxxxxxx) X315 X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X361x X332 X335 X373 (xxxxxxx) X315 X317 X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100“
„616-207-00-X	xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx; XXXX	—	32289-58-0 27083-27-8	Xxxx. 2 Xxxxx Tox. 2 Acute Xxx. 4 XXXX XX 1 Xxx Xxx. 1 Xxxx Xxxx. 1X Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X351 X330 X302 X372 (xxxxxxx cesty) (vdechnutí) H318 H317 H400 H410	GHS08 GHS06 GHS05 GHS09 Dgr	H351 H330 H302 H372 (xxxxxxx cesty) (xxxxxxxxx) X318 X317 X410		X&xxxx;= 10 X&xxxx;= 10“

X&xxxx;xxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxxxxx xxxxx xx xxxxxxxx tyto xxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxxxxx identifikace chemických xxxxx	Xxxxx ES	Číslo XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx	Xxxx.
Xxxxxxxx xxxxx	Xxxxxxxxxxx identifikace chemických xxxxx	Xxxxx ES	Číslo XXX	Xxxx xxxx a kategorií xxxxxxxxxxxxx	Xxxx standardních xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx slov	Kódy xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxx. xxxxxxxxxxxx xxx o nebezpečnosti	Xxxxxxxxxx xxxxxxx. xxxxxx, xxxxxxxxxxxxx xxxxxxx	Xxxx.
„005-020-00-3	oktaboritan xxxxxxx, xxxxxxx; [1] xxxxxxxxxxx xxxxxxx xxxxxxxxxxx [2]	234-541-0 [1] 234-541-0 [2]	12008-41-2 [1] 12280-03-4 [2]	Xxxx. 1X	X360XX	XXX08 Xxx	X360XX“
„014-046-00-4	xxxxxxxxxxx X-xxxx xxxxxxxxxxxxxxxxx xxxxxxx; [vápenato-hlinito-křemičitá xxxxxx x&xxxx;xxxxxxxx orientací x&xxxx;xxxxx xxxxxxxxxxxxxxxx složením (x&xxxx;% hmotnostních): SiO2 50,0-56,0 %, Xx2X3&xxxx;13,0-16,0 %, X2X3&xxxx;5,8-10,0 %, Na2O &xx;&xxxx;0,6 %, X2X &xx;&xxxx;0,4 %, CaO 15,0-24,0 %, XxX &xx;&xxxx;5,5 %, Xx2X3 &xx;&xxxx;0,5 %, F2 &xx;&xxxx;1,0 %. Xxxxxx: xxxxxxx xxxx vyráběna xxxxxxxxxxxxxx xxxxxxxx a rotačním xxxxxxxx. (Xxxxx jednotlivé xxxxx xxxxx xxx xxxxxxxx v nízkých xxxxxxxxxxxxx; xxxxxx xxxxxxx xxxxxxxxxx xxxxxxx).]	—	—	Xxxx. 1B	H350i	GHS08 Dgr	H350i			A“
„014-047-00-X	skleněná mikrovlákna xxxxxxxxxxxxxxxxx složení; [xxxxxxxx-xxxxxxx-xxxxxxxxx xxxxxx s náhodnou xxxxxxxxx x&xxxx;xxxxx složením (x&xxxx;% xxxxxxxxxxxx): XxX2&xxxx;55,0-60,0 %, Xx2X3&xxxx;4,0-7,0 %, B2O3 8,0-11,0 %, XxX2&xxxx;0,0-4,0 %, Xx2X 9,5-13,5 %, X2X 0,0-4,0 %, XxX 1,0-5,0 %, XxX 0,0-2,0 %, Xx2X3 &xx;&xxxx;0,2 %, XxX 2,0-5,0 %, XxX 3,0-6,0 %, X2 < 1,0 %. Xxxxxx: xxxxxxx xxxx xxxxxxxx rozvlákňováním xxxxxxxx x&xxxx;xxxxxxxx xxxxxxxx. (Xxxxx xxxxxxxxxx xxxxx xxxxx xxx xxxxxxxx x&xxxx;xxxxxxx xxxxxxxxxxxxx; xxxxxx procesů xxxxxxxxxx inovace).]	—	—	Carc. 2	X351 (xxxxxxxxx)	XXX08 Xxx	X351 (xxxxxxxxx)			X“
„029-015-00-0	xxxxxxxxxxxx xxxxx	214-183-1	1111-67-7	Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410	XXX032	X&xxxx;= 10“
„029-016-00-6	oxid xxxxxxx	215-269-1	1317-38-0	Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 100“
„029-017-00-1	xxxxxxx-xxxxxxxxxxx xxxxxxxxx	215-572-9	1332-65-6	Xxxxx Xxx. 4 Xxxxx Xxx. 3 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X332 X301 X400 X410	XXX06 XXX09 Xxx	X332 X301 X410		X&xxxx;= 10“
„029-018-00-7	xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx; [1] xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx xxxxxx [2]	215-582-3 [1] 215-582-3 [2]	1333-22-8 [1] 12527-76-3 [2]	Xxxxx Xxx. 4 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X302 X400 X410	XXX07 XXX09 Xxx	X302 X410		X&xxxx;= 10“
„029-019-01-X	xxxxxx xxxxxx (xxxxxxxx alifatickou xxxxxxxxx)	—	—	Xxxxx Xxx. 3 Xxxxx Xxx. 4 Xxx Xxxxx. 2 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X331 X302 X319 X400 X410	XXX06 XXX09 Xxx	X331 X302 X319 X410		X&xxxx;= 10“
„029-020-00-8	xxxxxxxxx xxxxxxx – hydroxid xxxxxxx (1:1)	235-113-6	12069-69-1	Xxxxx Tox. 4 Xxxxx Xxx. 4 Xxx Xxxxx. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H332 H302 H319 H400 H410	GHS07 GHS09 Wng	H332 H302 H319 H410		M = 10“
„029-021-00-3	xxxxxxxx měďnatý	243-815-9	20427-59-2	Acute Xxx. 2 Xxxxx Xxx. 4 Eye Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	H330 H302 H318 H400 H410	GHS06 GHS05 GHS09 Dgr	H330 H302 H318 H410		M = 10“
„029-022-00-9	xxxxxxxxxxx xxxxx; xxxxxxx xxxxxxxx xxxxxx měďnatého x&xxxx;xxxxxxxxx xxxxxxxxxx	—	8011-63-0	Xxxxx Tox. 4 Xxx Xxx. 1 Xxxxxxx Acute 1 Xxxxxxx Chronic 1	X332 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X332 X318 X410		X&xxxx;= 10“
„029-023-00-4	xxxxx xxxxxxx, pentahydrát	231-847-6	7758-99-8	Acute Xxx. 4 Eye Dam. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H302 H318 H400 H410	GHS07 GHS05 GHS09 Dgr	H302 H318 H410		M = 10“
„082-013-00-1	olověný xxxxxx; [xxxxxx xxxxxx &xx;&xxxx;1&xxxx;xx]	231-100-4	7439-92-1	Xxxx. 1&xxxx;X Xxxx.	X360XX X362	XXX08 Xxx	X360XX X362		Xxxx. 1 A; X360X: X ≥ 0,03 %“
„082-014-00-7	xxxxxxxx xxxxx: [xxxxxx částic ≥&xxxx;1&xxxx;xx]	231-100-4	7439-92-1	Xxxx. 1&xxxx;X Xxxx.	X360XX X362	XXX08 Xxx	X360XX X362“
„605-040-00-8	xxxxxxxxxxxxxxx-3-xxxxxxxxxx-xxxxxxxxxxxxx (XXXX); xxxxxxx xxxx 4-(4-hydroxy-4-methylpentyl)cyklohex-3-en-1-karbaldehydu x&xxxx;3-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxxx; [1] 4-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxx; [2] 3-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxx [3]	- [1] 250-863-4 [2] 257-187-9 [3]	130066-44-3 [1] 31906-04-4 [2] 51414-25-6 [3]	Skin Xxxx. 1&xxxx;X	X317	XXX07 Xxx	X317“
„607-716-00-8	xxxxxxxxxxx (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-3-xxxxxxx-1-xxxxxxxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	249-205-9	28772-56-7	Xxxx. 1B Acute Tox. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 1 STOT XX 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (krev) H400 H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H310 H300 H372 (xxxx) X410		Xxxx. 1X; X360X: X ≥&xxxx;0,003 % STOT XX 1; H372 (xxxx): X ≥&xxxx;0,005 % XXXX XX 2; X373 (krev): 0,0005 % ≤ X < 0,005 % X&xxxx;= 1 X&xxxx;= 1“
„607-717-00-3	xxxxxxxxxxx (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxxxxxxxxxx-1-xx]-4-xxxxxxx-2X-1-xxxxxxxxxxxxxx-2-xx	—	104653-34-1	Xxxx. 1X Xxxxx Xxx. 1 Xxxxx Tox. 1 Acute Xxx. 1 STOT RE 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410	XXX070	Xxxx. 1X; X360X: X ≥&xxxx;0,003 % STOT RE 1; X372 (xxxx): X ≥&xxxx;0,02 % XXXX XX 2; X373 (krev): 0,002 % ≤ X &xx;&xxxx;0,02 % X&xxxx;= 100 X&xxxx;= 100“
„607-718-00-9	xxxxxxxxxxxxx-1-xxx xxxxxxxx [1] x&xxxx;xxxx xxxxx [2] x&xxxx;xxxxxx [3] soli	206-801-3 [1] [2] [3]	375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3]	Xxxx. 2 Xxxx. 1X Xxxx. Xxxxx Tox. 4 Xxxxx Xxx. 4 XXXX XX 1 Xxx Dam. 1	X351 X360Xx X362 X332 X302 X372 (xxxxx, xxxxxx, xxxxxxx) X318	XXX08 XXX07 XXX05 Xxx	X351 X360Xx X362 X332 X302 X372 (xxxxx, xxxxxx, xxxxxxx) X318“
„607-719-00-4	xxxxxxxxxxxx-xxxxxx	201-545-9	84-61-7	Xxxx. 1X Xxxx Sens. 1	X360X X317	XXX08 XXX07 Xxx	X360X X317“
„608-067-00-3	3,7-xxxxxxxxxxxx-2,6-xxxxxxxxxx	225-918-0	5146-66-7	Xxxx. 1B	H340	GHS08 Dgr	H340“
„612-288-00-0	bupirimát (XXX); 5-xxxxx-2-xxxxxxxxxx-6-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxxxxxxxxx	255-391-2	41483-43-6	Xxxx. 2 Xxxx Xxxx. 1X Xxxxxxx Xxxxxxx 1	X351 X317 X410	XXX08 XXX07 XXX09 Xxx	X351 X317 X410		X&xxxx;= 1“
„612-289-00-6	xxxxxxxxxxx (XXX); (1X)-X-[4-xxxxx-2-(xxxxxxxxxxxxxx)xxxxx]-1-(1X-xxxxxxxx-1-xx)-2-xxxxxxxxxxxxxxxx	—	68694-11-1	Xxxx. 1B Acute Xxx. 4 XXXX RE 2 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	H360D H302 H373 (xxxxx) X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X360X X302 X373 (játra) H317 H410		M = 1 X&xxxx;= 1“
„616-218-00-X	xxxxxxxxxxxxxxxx (XXX); N-[9-(dichlormethylen)-1,2,3,4-tetrahydro-1,4-methanonaftalen-5-yl]-3-(difluormethyl)-1-methyl-1H-pyrazol-4-karboxamid	—	1072957-71-1	Acute Xxx. 3 Xxxxx Xxx. 3 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X331 X301 X400 X410	XXX06 XXX09 Xxx	X331 X301 X410		X&xxxx;= 100 X&xxxx;= 100“
„616-219-00-5	xxxxxxxxx (ISO); N-{2-[3-chlor-5-(trifluormethyl)pyridin-2-yl]ethyl}-2-(trifluormethyl)benzamid	—	658066-35-4	Aquatic Xxxxxxx 2	X411	XXX09	X411“
„616-220-00-0	xxxxxxxxxx (XXX); 1-[(4-xxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxx-3-xxxxxxxxxxxxx	266-096-3	66063-05-6	Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 1 X&xxxx;= 1“
„617-023-00-2	xxxx-xxxxxxxxxxxxxxxxx	200-915-7	75-91-2	Xxxx. 2	X341	XXX08 Xxx	X341“

Plné znění - 32016R1179

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32016R1179

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.